The purpose of this study is to investigate the prognostic value of admission high-sensitivity troponin in patients with acute decompensated heart failure.
Patients admitted for acute decompensated heart failure are included in the study. After gaining informed consent, concentrations of high-sensitivity troponin on admission and on discharge are assessed. 6 months after discharged, the incidence of clinical endpoint (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by telephone contact to the patient and/or the physician. The aim of the study is to investigate the prognostic value of high-sensitivity troponin concentration for predicting death and re-hospitalization.
Study Type
OBSERVATIONAL
Enrollment
304
Innere Medizin III - Kardiologie, Angiologie und Internistische Intensivtherapie
Homburg, Saarland, Germany
Time to cardiovascular death or hospitalization
Time frame: 6 Months Follow-Up
Time to all cause death or hospitalization
Time frame: 6 Months Follow-Up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.